Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

[Alexithymia--definition, causes and participation in the etiology of diseases].

Orzechowska A, Denys K, Gałecki P.

Pol Merkur Lekarski. 2014 Aug;37(218):128-33. Review. Polish.

PMID:
25252451
[PubMed - indexed for MEDLINE]
2.

[Comparison of increase in depressive disorders in dependence of BMI value].

Kuśmierek M, Błaszczyk J, Talarowska M, Orzechowska A, Bobińska K, Gałecki P.

Pol Merkur Lekarski. 2014 Aug;37(218):91-5. Polish.

PMID:
25252442
[PubMed - indexed for MEDLINE]
3.

Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder.

Talarowska M, Orzechowska A, Szemraj J, Su KP, Maes M, Gałecki P.

Neuropsychobiology. 2014;70(1):23-8. doi: 10.1159/000363340. Epub 2014 Aug 21.

PMID:
25171019
[PubMed - in process]
4.

Myeloperoxidase gene expression and cognitive functions in depression.

Talarowska M, Szemraj J, Gałecki P.

Adv Med Sci. 2014 Jun 26;60(1):1-5. doi: 10.1016/j.advms.2014.06.001. [Epub ahead of print]

PMID:
25038328
[PubMed - as supplied by publisher]
5.

[Creutzfeldt-Jakob disease in the psychiatric practice--case reports of the ataxic and Heidenhain variant].

Berent D, Baczek I, Florkowski A, Gałecki P.

Psychiatr Pol. 2014 Jan-Feb;48(1):187-94. Polish.

PMID:
24946444
[PubMed - indexed for MEDLINE]
6.

ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder.

Talarowska M, Szemraj J, Zajączkowska M, Gałecki P.

Med Sci Monit. 2014 Jun 2;20:905-12. doi: 10.12659/MSM.890160.

PMID:
24881886
[PubMed - in process]
Free PMC Article
7.

The Glutathione System: A New Drug Target in Neuroimmune Disorders.

Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, Maes M.

Mol Neurobiol. 2014 Apr 22. [Epub ahead of print]

PMID:
24752591
[PubMed - as supplied by publisher]
8.
9.

[Prosopagnosia--a case report].

Talarowska M, Pietrzyk-Orkisz K, Wilińska J, Gałecki P.

Pol Merkur Lekarski. 2013 Nov;35(209):283-6. Polish.

PMID:
24575649
[PubMed - indexed for MEDLINE]
10.

Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder.

Gałecki P, Talarowska M, Bobińska K, Kowalczyk E, Gałecka E, Lewiński A.

Neuro Endocrinol Lett. 2013;34(8):780-6.

PMID:
24522026
[PubMed - indexed for MEDLINE]
11.

Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders.

Talarowska M, Bobińska K, Zajączkowska M, Su KP, Maes M, Gałecki P.

Med Sci Monit. 2014 Jan 24;20:110-5. doi: 10.12659/MSM.889853.

PMID:
24457625
[PubMed - in process]
Free PMC Article
12.

Thyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder.

Berent D, Zboralski K, Orzechowska A, Gałecki P.

Mol Biol Rep. 2014 Apr;41(4):2419-25. doi: 10.1007/s11033-014-3097-6. Epub 2014 Jan 18.

PMID:
24443228
[PubMed - in process]
Free PMC Article
13.

COX-2 gene expression is correlated with cognitive function in recurrent depressive disorder.

Gałecki P, Talarowska M, Bobińska K, Szemraj J.

Psychiatry Res. 2014 Feb 28;215(2):488-90. doi: 10.1016/j.psychres.2013.12.017. Epub 2013 Dec 18.

PMID:
24388097
[PubMed - in process]
14.

Depression and ways of coping with stress: a preliminary study.

Orzechowska A, Zajączkowska M, Talarowska M, Gałecki P.

Med Sci Monit. 2013 Nov 25;19:1050-6. doi: 10.12659/MSM.889778.

PMID:
24270182
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Morris G, Berk M, Galecki P, Maes M.

Mol Neurobiol. 2014 Apr;49(2):741-56. doi: 10.1007/s12035-013-8553-0. Epub 2013 Sep 26.

PMID:
24068616
[PubMed - in process]
16.

Working memory impairment as a common component in recurrent depressive disorder and certain somatic diseases.

Galecki P, Talarowska M, Moczulski D, Bobinska K, Opuchlik K, Galecka E, Florkowski A, Lewinski A.

Neuro Endocrinol Lett. 2013;34(5):436-45.

PMID:
23922050
[PubMed - indexed for MEDLINE]
17.

[Correlations between working memory effectiveness and depression levels after pharmacological therapy].

Talarowska M, Zboralski K, Gałecki P.

Psychiatr Pol. 2013 Mar-Apr;47(2):255-67. Polish.

PMID:
23888759
[PubMed - indexed for MEDLINE]
18.

[Subjective evaluation of symptoms and effects of treatment and the intensity of the stress and anxiety levels among patients with selected diseases of the skin and gastrointestinal tract].

Orzechowska A, Talarowska M, Zboralski K, Florkowski A, Gałecki P.

Psychiatr Pol. 2013 Mar-Apr;47(2):225-37. Polish.

PMID:
23888757
[PubMed - indexed for MEDLINE]
19.

[The prevalence of suicide attempts among children and adolescents].

Woźniak E, Talarowska M, Orzechowska A, Florkowski A, Gałecki P.

Pol Merkur Lekarski. 2013 Mar;34(201):154-7. Polish.

PMID:
23700825
[PubMed - indexed for MEDLINE]
20.

Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development.

Gałecki P, Gałecka E, Maes M, Orzechowska A, Berent D, Talarowska M, Bobińska K, Lewiński A, Bieńkiewicz M, Szemraj J.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:117-24. doi: 10.1016/j.pnpbp.2013.04.011. Epub 2013 May 11.

PMID:
23673188
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk